Inhibition of TARBP2 expression promoted sorafenib resistance in PLC5 cells (Fig. 2G,H), indicating that downregulation of TARBP2 facilitates sorafenib resistance in HCC cells. This evidence concerns the gene TARBP2 and hepatocellular carcinoma.